Systemic Lupus Erythematosus (SLE) is a chronic, inflammatory disease. Recent studies demonstrated an increased incidence of osteoporosis (OP) and fractures in SLE patients. Glucocorticoids (Gcs) are part of therapy for SLE and have with long-term intake deleterious effects on bone quality leading ultimately to Glucocorticoido-induced-osteoporosis. Our aim was to assess the marrow composition of a SLE population and compare it to that of OP patients, GCs user and young healthy women using 3T Chemical Shift Encoded- MRI (CSE-MRI).
This abstract and the presentation materials are available to members only; a login is required.